KNC Laboratories Co Ltd
TSE:6568

Watchlist Manager
KNC Laboratories Co Ltd Logo
KNC Laboratories Co Ltd
TSE:6568
Watchlist
Price: 1 335 JPY 1.83% Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

16.3B
+14%
Assets
Growth Rates:
1 Year
+23%
3 Years
+31%
5 Years
+39%
7 Years
-
10 Years
-
4.2B
+92%
Liabilities
Growth Rates:
1 Year
+69%
3 Years
+66%
5 Years
+57%
7 Years
-
10 Years
-
12.1B
+0.4%
Equity
Growth Rates:
1 Year
+12%
3 Years
+23%
5 Years
+33%
7 Years
-
10 Years
-

Balance Sheet Decomposition
KNC Laboratories Co Ltd

16.3B
Assets
4.2B
Liabilities
16.3B
Assets
4.2B
Liabilities
Current Assets 7.3B
Cash & Short-Term Investments 2.6B
Receivables 972.9m
Other Current Assets 3.7B
Non-Current Assets 9.1B
PP&E 7.6B
Intangibles 49.8m
Other Non-Current Assets 1.4B
Current Liabilities 2.3B
Accounts Payable 305m
Accrued Liabilities 129.6m
Other Current Liabilities 1.9B
Non-Current Liabilities 1.9B
Long-Term Debt 1.4B
Other Non-Current Liabilities 418.8m

Balance Sheet
KNC Laboratories Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
869
1 263
5 413
3 072
1 476
1 963
1 974
2 297
Cash Equivalents
869
1 263
5 413
3 072
1 476
1 963
1 974
2 297
Total Receivables
658
834
686
505
1 527
1 142
2 518
2 791
Accounts Receivables
658
834
686
505
1 527
1 142
2 518
2 791
Other Receivables
0
0
0
0
0
0
0
0
Inventory
681
942
976
1 097
1 286
1 743
1 772
2 280
Other Current Assets
339
147
49
100
46
290
83
91
Total Current Assets
2 547
3 185
7 125
4 775
4 335
5 137
6 347
7 459
PP&E Net
5 799
5 340
5 135
6 628
7 696
6 961
6 909
7 200
PP&E Gross
0
5 340
0
6 628
7 696
6 961
6 909
7 200
Accumulated Depreciation
0
8 529
0
9 731
10 387
11 158
11 928
12 492
Intangible Assets
216
39
29
79
84
61
46
64
Long-Term Investments
177
152
213
294
337
281
254
233
Other Long-Term Assets
34
123
187
227
319
341
395
449
Total Assets
8 773
N/A
8 839
+1%
12 688
+44%
12 002
-5%
12 771
+6%
12 781
+0%
13 952
+9%
15 405
+10%
Liabilities
Accounts Payable
328
499
463
257
233
256
278
306
Accrued Liabilities
162
411
438
340
373
360
535
490
Short-Term Debt
300
300
0
0
0
0
200
500
Current Portion of Long-Term Debt
733
680
1 279
778
460
360
440
440
Other Current Liabilities
414
405
794
958
650
311
594
993
Total Current Liabilities
1 937
2 295
2 974
2 333
1 716
1 287
2 047
2 728
Long-Term Debt
2 937
2 257
978
200
968
1 083
1 037
597
Deferred Income Tax
146
98
0
0
0
0
0
0
Other Liabilities
6
6
0
15
259
290
293
335
Total Liabilities
5 025
N/A
4 655
-7%
3 952
-15%
2 547
-36%
2 944
+16%
2 660
-10%
3 377
+27%
3 659
+8%
Equity
Common Stock
0
100
1 952
1 952
1 969
1 983
1 995
1 995
Retained Earnings
3 484
4 033
4 844
5 587
5 913
6 119
6 568
7 830
Additional Paid In Capital
100
0
1 852
1 852
1 869
1 883
1 895
1 895
Unrealized Security Profit/Loss
0
51
89
64
75
137
116
103
Treasury Stock
0
0
0
0
0
0
0
78
Other Equity
91
0
0
0
0
0
0
0
Total Equity
3 748
N/A
4 184
+12%
8 737
+109%
9 455
+8%
9 827
+4%
10 121
+3%
10 575
+4%
11 745
+11%
Total Liabilities & Equity
8 773
N/A
8 839
+1%
12 688
+44%
12 002
-5%
12 771
+6%
12 781
+0%
13 952
+9%
15 405
+10%
Shares Outstanding
Common Shares Outstanding
6
6
8
8
8
8
8
8

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.